HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S3-6. Unique Identifier : AIDSLINE MED/95169505
Vlahov D; Johns Hopkins School of Hygiene and Public Health, Baltimore,; Maryland.

Abstract: Human immunodeficiency virus (HIV) infection among injecting drug users remains a major health problem. Traditional approaches to prevent parenteral transmission of HIV infection in this population include abstinence facilitated through treatment for drug abuse, HIV testing with education and counseling, disinfection of needles with bleach between uses, and needle exchange programs. While each of these strategies are important and contribute to risk reduction, high-risk behavior and transmission of HIV infection continues. The development and distribution of safe and effective HIV vaccines in this population is urgently needed.
Keywords: AIDS Vaccines/*PHARMACOLOGY Disinfection Human HIV Infections/COMPLICATIONS/*PREVENTION & CONTROL/TRANSMISSION Needle-Exchange Programs Needles Risk-Taking Sodium Hypochlorite *Substance Abuse, Intravenous/COMPLICATIONS/THERAPY Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDaidsvaccines/KWDpharmacologydisinfectionhumanhivinfections/complications/KWDprevention&control/transmissionneedle-exchangeprogramsneedlesrisk-takingsodiumhypochloriteKWDsubstanceabuse,intravenous/complications/therapysupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticlereviewreview,tutorial
950630
M9561111

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .